Japan’s cost-effectiveness assessment (CEA) panel has approved a revised handling policy for the CEA system for FY2026, with the health…
BUSINESS
Astellas/Vical’s CMV Vaccine Flops in Global PIII
Astellas Pharma said on January 22 that ASP0113, an investigational cytomegalovirus (CMV) vaccine being codeveloped with US biotech Vical, failed to achieve both primary and secondary endpoints in a global PIII study covering hematopoietic stem cell transplant (HSCT) recipients. The…
To read the full story
Related Article
BUSINESS
- Otsuka’s Centanafadine Accepted for FDA Review with Priority Tag
January 28, 2026
- Sato Enters Smoking Cessation Market via Nicotinell Tie-Up with Dr. Reddy’s
January 27, 2026
- Top Court Rejects Samsung Challenge to Patent-Linkage Disclosures in Eylea Biosimilar Case
January 27, 2026
- Quviviq, Dayvigo Top 3 Promotion Channels in December: Intage
January 27, 2026
- Ajinomoto Builds Presence in ADC CDMO Business with Proprietary Technology
January 27, 2026
The Japanese healthcare sector is experiencing rapid growth, demanding a highly skilled and diverse workforce. However, finding and attracting the best talent in this competitive market presents significant challenges.Enter AI. With the rise of AI-powered tools, healthcare organizations can revolutionize…
As many as 47 new drug candidates are expected to win approval or secure NHI price listing in Japan in…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…